Cancer and gene therapy

Annals of Hematology

Volumn 73, Issue 5, 1996, Pages 207-218

  Schmidt Wolf, G D ^a   Schmidt Wolf, I G H ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Cancer; Gene therapy; Gene transfer; Review

Indexed keywords

CANCER; GENE TARGETING; GENE THERAPY; HUMAN; PRIORITY JOURNAL; REVIEW; TUMOR IMMUNOLOGY;

GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; IMMUNOTHERAPY; METHODS; NEOPLASMS;

EID: 0029821541     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050231     Document Type: Review

References (190)

1. Agarwal R, Doren S, Hicks B, Dunbar CE (1995) Long-term culture of chronic myelogenous leukemia marrow cells on stem cell factor-deficient stroma favors benign progenitors. Blood 85:1306-1312
2. Andersen JK, Garber DA, Meaney CA, Breakfield XO (1992) Gene transfer into mammalian central nervous system using herpes virus vectors. Hum Gene Ther 3:487-499
3. Anderson WF (1994) Gene therapy for cancer. Hum Gene Ther 5:1-2
4. Andreason GL, Evans GA (1988) Introduction and expression of DNA molecules in eukaryotic cells by electroporation. Biotechnology 6:650-659
5. Austin EA, Huber BE (1993) A first step in the development of gene therapy for colorectal carcinoma. Cloning, sequencing and expression of E coli cytosine deaminase. Mol Pharmacol 43:380-387
6. Averett DR, Koszalka GW, Fyfe JA, Roberts GB, Purifoy DJM, Krenitsky TA (1991) 6-Methoxypurine arabinoside as a selective and potent inhibitor of varicella-zoster virus. Antimicrob Agents Chemother 35:851-857
7. Baker SJ, Markowitz S, Fearon ER, Willson JK, Vogelstein B (1990) Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249:912-915
8. Banerjee D, Zhao SC, Li M-X, Schweitzer BI, Mineishi S, Bertino JR (1993) Gene therapy utilizing drug resistance genes: a review. Stem Cells 12:378-385
9. Bank A (1994) A phase-I study of gene therapy for breast cancer. Hum Gene Ther 5:102-106
10. Baxter TL (1986) The somatomedins: insulin-like growth factors. Adv Clin Chem. 25:49-115
11. Bishop JM (1991) Molecular themes in carcinogenesis. Cell 64:235-248
12. Bookstein R, Shew J-Y, Chen P-L, Scully P, Lee W-H (1990) Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated rb gene. Science 247:712-715
13. Bordignon C, Bonini C, Verzeletti S (1995) Clinical protocol. Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor antitumor immunity after allogeneic bone marrow transplantation. Hum Gene Ther 6:813-819
14. Bos JI (1989) Ras oncogenes in human cancer: a review. Cancer Res 49:4682-4689
15. Brenner MK (1994) Genetic marking and manipulation of hematopoietic progenitor cells using retroviral vectors. Immunomethods 5:204-210
16. Brenner MK, Rill DR, Holladay MS, Heslop HE, Moen RC, Buschle M, Krance RA, Santana VM, Anderson WF, Ihle JN (1993) Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 342:1134-1137
17. Brenner MK, Rill DR, Moen RC, Krance RA, Mirro JJ, Anderson WF, Ihle JN (1993) Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 341:85-86
18. Buschle M, Cotten M, Kirlappos H, Mechtler K, Schaffner G, Zauner W, Birnstiel.ML, Wagner E (1995) Receptor-mediated gene transfer into human T lymphocytes via binding of DNA/CD3 antibody particles to the CD3 T cell receptor complex. Hum Gene Ther 6:753-761
19. Cai Q, Rubin J, Lotze M (1995) Genetically marking human cells - results of the first clinical gene transfer studies. Cancer Gene Ther 2:125-136
20. Caruso M, Panis Y, Gagandeep S, Houssin D, Salzmann JL, Klatzmann D (1993) Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc Natl Acad Sci U S A 90:7024-7028
21. Cascinelli N, Foa R, Parmiani G (1994) Active immunization of metastatic melanoma patients with IL-4 transduced allogeneic melanoma cells. A phase I-II study. Hum Gene Ther 5:1059-1064
22. Casson AG, Mukhopadhyay T, Cleary KR, Ro JY, Levin B, Roth JA (1991) p53 gene mutations in Barrett's epithelium and esophageal cancer. Cancer Res 51:4495-4499
23. Chabner BA, Collins JM (1990) Chemotherapy administration: practical guidelines. In: Cancer chemotherapy principles and practice. Lippincott, Philadelphia, pp 449-464
24. Chen P-L, Chen Y, Bookstein R, Lee W-H (1990) Genetic mechanisms of tumor suppression by the human p53 gene. Science 250:1576-1580
25. Chen SY, Bagley J, Marasco WA (1994) Intracellular antibodies as a new class of therapeutic molecules for gene therapy. Hum Gene Ther 5:595-601
26. Cohen JS (1994) Gene-mimetic substances: drugs designed to intervene in gene expression. Adv Pharmacol 25:319-339
27. Colombo BM, Benedetti S, Ottolenghi S, Mora M, Polio B, Poli G, Finocchiaro G (1995) The "bystander" effect: association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice. Hum Gene Ther 6:763-772
28. Colombo MP, Ferrari G, Stoppacciaro A, Parenza M, Rodolfo M, Mavilio F, Parmiani G (1991) Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo. J Exp Med 173:889-897
29. Colombo MP, Lombardi L, Stoppacciaro A, Melani C, Parenza M, Bottazzi B, Parmiani G (1992) Granulocyte colony-stimulating factor (G-CSF) gene transduction in murine adenocarcinoma drives neutrophil-mediated tumor inhibition in vivo. Neutrophils discriminate between G-CSF-producing and G-CSF-nonproducing tumor cells. J Immunol 149:113-119
30. Connor J, Bannerji R, Saito S, Heston W, Fair W, Gilboa E (1993) Regression of bladder tumor in mice treated with interleukin-2 gene-modified tumor cells. J Exp Med 177:1127-1134
31. Corey CA, DeSilva AD, Holland CA, Williams DA (1990) Serial transplantation of methotrexate-resistant bone marrow. Blood 75:337-343
32. Cornetta K (1992) Retroviral-mediated gene transfer of bone marrow cells during autologous bone marrow transplantation for acute leukemia. Human Gene Therapy 3:305-318
33. Cotin RM, Linden RM, Berns KI (1992) Characterization of a preferred site on human chromosome 19q for integration of AAV DNA by non-homologous recombination. EMBO J 11:5071-5078
34. Culver KW, Ram Z, Walbridge S, Ishii H, Oldfield EH, Blaese RM (1992) In vivo gene transfer with retroviral vector producer cells for treatment of experimental brain tumors. Science 256:1550-1552
35. Curiel DT, Agarwal S, Wagner E, Cotten M (1991) Adenovirus enhancement of transferrin-polylysine-mediated gene delivery. Proc Natl Acad Sci U S A 88:8850-8854
36. Curiel TJ, Cook DR, Wang Y, Hahn BH, Harrison GS (1993) Long-term inhibition of clinical and laboratory human immunodeficiency virus strains in human T-cell lines containing an HIV-regulated diphtheria toxin A chain gene. Hum Gene Ther 4:741-747
37. Dawson M, Moore M (1989) Tumour immunology: immunological escape. In: Roitt IM, Brostoff J, Male DK (eds) Immunology. 2nd edn Mosby/Gower, St. Louis, pp 18.13-18.14
38. Deisseroth AB, Zu ZF, Claxton D, Hanania EG, Fu SQ., Ellerson D, Goldberg L, Thomas M, Janicek K, Anderson WF, Hester J, Korbling M, Durett A, Moen R, Berenson R, Heimfeld S, Hamer J, Calvert L, Tibbits P, Talpaz M, Kantarjian H, Champlin R, Reading C (1994) Genetic marking shows that Ph(+) cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow transplantation. Blood 83:3068-3076
39. Deonarain MP, Spooner RA, Epenetos AA (1995) Genetic delivery of enzymes for cancer therapy. Gene Ther 2:235-244
40. Devine SE, Meleras PW (1994) Diversity of multidrug resistance in mammalian cells. J Biol Chem 269:6133-6139
41. Dillon N (1993) Regulating gene expression in gene therapy. Trends Biotechnol 11:167-173
42. Donahue RE, Kessler SW, Bodine D, McDonagh K, Dunbar C, Goodman S, Agricola B, Byrne E, Raffeld M, Moen R (1992) Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med 176:1125-1135
43. Drannoff G, Jaffe EM, Lazenby A, Golumbek P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll EM, Mulligan RC (1993) Vaccination with irradiated tumor cells engineered to secrete murine GM-CSF stimulates potent, specific and long-lasting anti-tumor immunity. Proc Natl Acad Sci U S A 90:3539-3543
44. Dunbar CE, O'Shaughnessy JA, Cottler-Fox M, Carter CS, Doren S, Cowan KH, Leitman SF, Wilson W, Young NS, Nienhuis AW (1993) Transplantation of retrovirally marked CD34 + bone marrow and peripheral blood cells in patients with multiple myeloma or breast cancer (abstract). Blood 82 [Suppl 1]:217a
45. Duovdevani A, Muleihel M, Zoellner M, Segal S, Apte RN (1992) Reduced tumorigenicity of fibrosarcomas which constitutively generate IL-1 alpha either spontaneously or following IL-1 alpha gene transfer. Int J Cancer 51:822-830
46. Elkins KL, Ennist DL, Winegar RK, Weir JP (1994) In vivo delivery of interleukin-4 by a recombinant vaccinia virus prevents tumor development in mice. Hum Gene Ther 5:809-820
47. Farhood H, Gao X, Son K, Yang YY, Lazo JS, Huang L, Barsoum J, Bottega R, Epand RM (1994). Cationic liposomes for direct gene transfer in therapy of cancer and other diseases. Ann NY Acad Sci 716:23-34
48. Finke S, Trojaneck B, Lefterova P, Csipai M, Wagner E, Kircheis R, Neubauer A, Huhn D, Wittig B, Schmidt-Wolf IGH (1996) Increase of proliferation rate and enhancement of antitumor cytotoxicity of human immunologic effector cells by transfection with the interleukin-7 gene. Blood, (submitted for publication)
49. Finke S, Trojaneck B, Moeller P, Schadendorf D, Neubauer A, Huhn D, Schmidt-Wolf IGH (1996) Increase of cytotoxic sensitivity of primary human melanoma cells transfected with the interleukin-7 gene. Cancer Gene Therapy (submitted for publication)
50. Florenes VA, Aamdal S, Myklebost O, Maelandsmo GM, Bruland OS, Fodstad O (1992) Levels of nm23 messenger RNA in metastatic melanomas inverse correlation to disease prognosis. Cancer Res 52:6088-6091
51. Forough R, Zhan X, MacPhee M, Friedman S, Enleka KA, Sayers T, Wiltrout RH, Maciag T (1993) Differential transforming abilities of non-secreted and secreted forms of human fibroblast growth factor-1. J Biol Chem 268:2960-2968
52. Friedmann T (1992) Gene therapy of cancer through restoration of tumor-suppressor functions? Cancer 70:1810-1817
53. Gansbacher B (1992) A pilot study of immunization with HLA-A2-matched allogenic melanoma cells that secrete interleukin-2 in patients with metastatic melanoma. Hum Gene Ther 3:677-690
54. Gao C, Huang L (1995) Cationic liposome-mediated gene transfer. Gene Ther 2:710-722
55. Geller AI, Keyomarsi K, Bryan J, Pardee AB (1990) An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology. Proc Natl Acad Sci U S A 87:8950-8954
56. Georges RN, Mukhopadhyay T, Zhang Y, Yen N, Roth JA (1993) Prevention of orthotopic human lung cancer growth by intratracheal instillation of a retroviral antisense K-ras construct. Cancer Res 53:1743-1746
57. Ghosh P, Sica A, Young HA (1994) Alterations in NKkB/ Rel family proteins in splenic T cells from tumor-bearing mice and reversal following therapy. Cancer Res 54:2969-2972
58. Gibbs J (1992) Pharmacological probes of ras function. Semin Cancer Biol 6:383-390
59. Golumbek PT, Lazenby AJ, Levitsky HI, Jaffe LM, Karas-uyama H, Baker M, Pardoll DM (1991) Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science 254:713-716
60. Goyette MC, Cho K, Fasching CL, Levy DB, Kinzler KW, Paraskewa C, Vogelstein B, Stanbridge EJ (1992) Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer. Mol Cell Biol 12:1387-1395
61. Graham FL, van der Eb AJ (1973) A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-467
62. Graham FL, Prevec L (1991) Adenovirus-based expression vectors and recombinant vaccines. In: Ellis RW (ed) Vaccines: new approaches to immunological problems. Butterworth-Heinemann, Oxford, England, pp 363-390
63. Gunter KC, Khan AS, Nogushi PD (1993) The safety of retroviral vectors. Hum Gene Ther 4:643-645
64. Harris JD, Gutierrez AA, Hurst HC, Sikora K, Lemoine NR (1994) Gene therapy for cancer using tumor-specific prodrug activation. Gene Ther 1:170-175
65. Harris JD, Hurst HC, Lemoine NR, Sikora K (1994) Therapeutic strategies using c-erbB-2 promoter controlled drug activation. Ann NY Acad Sci 124:115-125
66. Hawthorn RW, Tso CL, Kaboo R, et al (1994) In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin-2 and/or interferon alpha gene transfer. Cancer 74:1904-1911
67. Hesdorffer C (1994) Human MDR gene transfer in patients with advanced cancer. NIH review. Hum Gene Ther 5:1151-1160
68. Hirai H (1982) Alpha fetoprotein. In: Chu TM (ed) Biochemical markers for cancer. Marcel Dekker, New York, pp 23-59
69. Hollingsworth RE, Lee WE (1991) Tumor suppressor genes: new prospects for cancer research. J Natl Cancer Inst 83:91-96
70. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) P53 mutations in human cancers. Science 253:49-53
71. Holt JT, Gopal TV, Moulton AD, Nienhuis AW (1986) Inducible production of c-fos antisense RNA inhibits 3T3 cell orientation. Proc Natl Acad Sci U S A 83:4794-4799
72. Horn NA, Meek JA, Budahazi G, Marquet M (1995) Cancer gene therapy using plasmid DNA: purification of DNA for human clinical trials. Hum Gene Ther 6:565-573
73. Huang H-JS, Yee J-K, Shew J-Y, Chen P-L, Bookstein R, Friedmann T, Lee EY-H, Lee W-H (1988) Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 242:1563-1566
74. Huber BE, Richards CA, Krenitsky TA (1991) Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy. Proc Natl Acad Sci U S A 88:8039-8043
75. Huxley C (1994) Mammalian artificial chromosomes: a new tool for gene therapy. Gene Ther 1:7-12
76. Hwu P, Yannelli J, Kriegler M (1993) Functional and molecular characterization of tumor-infiltrating lymphocytes transduced with tumor necrosis factor-à cDNA for the gene therapy of cancer in humans. J Immunol 150:4104-4115
77. Iggo R, Gatter K, Bartek J, Lane D, Harris A (1990) Increased expression of mutant form of p53 oncogene in primary lung cancer. Lancet 335:675-679
78. Jenkins CD, Charles GI, Thomsen LL, Moss WD, Holmes SL, Baylis AS, Rhodes P, Westmore K, Binson PC, Moncada S (1995) Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 92:4392-4396
79. Johnston SA, Tang D (1993) The use of microparticle injection to introduce genes into animal cells in vitro and in vivo. In: Setlow JK (ed) Genetic engineering. Plenum, New York, pp 225-236
80. June CH, Bluestone JA, Nadler L, Thompson CB (1994) The B7 and CD28 receptor families. Immunol Today 15:321-331
81. Just U, Stocking C, Spooncer E, Dexter TM, Ostertag W (1991) Expression of the GM-CSF gene after retroviral transfer in hematopoietic stem cell lines induces synchronous granulocyte-macrophage differentiation. Cell 64:1163-1173
82. Kashani-Sabet M, Scanlon KJ (1995) Applications of ribozymes to cancer gene therapy. Cancer Gene Ther 2:213-223
83. Kishimoto T (1990) The biology of interleukin-6. Blood 74:1-10
84. Kozarsky KF, Wilson JM (1993) Gene therapy: adenovirus vectors. Curr Opin Genet Dev 3:499-503
85. Kradin RL, Bhan AK (1993) Tumor infiltrating lymphocytes. Lab Invest 69:635-638
86. Kun LE, Gajjar A, Muhlbauer M (1995) Clinical protocol. Stereotactic injection of herpes simplex thymidine kinase vector producer cells (PA317-G1Tk1SvNa.7) and intravenous ganciclovir for the treatment of progressive or recurrent primary supratentorial pediatric malignant brain tumors. Hum Gene Ther 6:1231-1255
87. Lane DP (1992) p53, Guardian of the genome. Nature 358:15-16
88. Ledley FD (1995) Review. Nonviral gene therapy: the promise of genes as pharmaceutical products. Hum Gene Ther 6:1129-1144
89. Leonetti J, Degols G, Clarenc JP (1993) Cell delivery and mechanisms of action of antisense oligonucleotides. Prog Nucleic Acid Res Mol Biol 44:143-166
90. Lesoon-Wood LA, Kim WH, Kleinman HK, Weintraub BD, Mixson AJ (1995) Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude mice. Hum Gene Ther 6:395-405
91. Levin L, Simon R, Hryniuk W (1993) Importance of multiagent chemotherapy regimens in ovarian carcinoma: dose intensity analysis. J Natl Cancer Inst 85:1732
92. Li X, Liu J, Park JK, Hamilton TA, Rayman P, Klein E, Edinger M, Tubbs R, Bukowski R, Finke J (1994) T cells from renal carcinoma patients exhibit an abnormal pattern of kB-specific DNA-binding activity: a preliminary report. Cancer Res 54:5424-5429
93. Lollini P-L, De Giovanni C, Landuzzi L, Nicoletti G, Frabetti F, Cavallo F, Giovarelli M, Forni G, Modica A, Modesti A, Musiani P, Nanni P (1995) Transduction of genes coding for a histocompatibility (MHC) antigen and for its physiological inducer interferon-gamma in the same cell: efficient MHC expression and inhibition of tumor and metastasis growth. Hum Gene Ther 6:743-752
94. Lotze MT, Rubin JT (1994) Gene therapy of cancer: a pilot study of IL-4 gene-modified fibroblasts admixed with autologous tumor to elicit an immune response. Hum Gene Ther 5:41-55
95. Mackiewicz A, Gorny A, Laciak M, Malicki J, Murawa P, Nowak J, Wizneroeicz M (1995) Clinical protocol. Gene therapy of human melanoma. Immunization of patients with autologous tumor cells admixed with allogeneic melanoma cells secreting interleukin 6 and soluble interleukin 6 receptor. Hum Gene Ther 6:805-811
96. Marcel T (1995) The RAC and Worldwide gene therapy report. TMC Development, 91 Av. Kleber F-75116 paris, France
97. Marshall C (1991) Tumor suppressor genes. Cell 64:313-326
98. Martial P, Lewalle P, Taj AS, Philippe M, Larondelle Y, Vaerman JL, Wildman C, Goldman JM, Michaux JL (1993) Retrovirally transduced antisense sequences stably suppress P210 BCR-ABL expression and inhibit the proliferation of BCR-ABL-containing cell lines. Blood 81:502-509
99. McBride WH, Thaker JD, Comora S, Economou JS, Kelley D, Hogge D, Dubinett SM, Dougherty GJ (1992) Genetic modification of a murine fibrosarcoma to produce interleukin 7 stimulates host cell infiltration and tumor immunity. Cancer Res 52:3931-3937
100. McGeady ML, Arthur PM, Seidman M (1990) Development of a retroviral vector for inducible expression of transforming growth factor ál. J Virol 64:3527-3531
101. Mercer WE, Shields MT, Lin D, Apella E, Ulrich SJ (1991) Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating nuclear antigen in colon carcinoma cell lines that express c-myb. Cancer Res 51:2897-2901
102. Miller DG, Adam MA, Miller AD (1990) Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10:4239-4242
103. Miller RM, McBride WH, Hunt K, Economou JS (1994) Cytokine-mediated gene therapy for cancer. Ann Surg 1:436-450
104. Mizuno M, Yoshida J, Sugita K, Inoue I, Seo H, Hayashi Y, Koshizaka T, Yagi K (1990) Growth inhibition of glioma cells transfected with the human beta-interferon gene by liposomes coupled with a monoclonal antibody. Cancer Res 50:7826-7829
105. Moolten FL (1994) Drug sensitivity ('suicide') genes for selective cancer chemotherapy. Cancer Gene Ther 1:279-287
106. Moolten FL, Wells JM (1990) Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J Natl Cancer Inst 82:297-300
107. Moolten FL, Cupples LA (1992) A model for predicting the risk of cancer consequent to retroviral gene therapy. Hum Gene Ther 3:479-486
108. Mukhopadhyay T, Tainsky M, Cavender AC, Roth JA (1991) Specific inhibition of K-ras expression and tumorigenicity of lung cancer cells by antisense RNA. Cancer Res 51:1744-1748
109. Mullen CA (1994) Metabolic suicide genes in gene therapy. Pharmacol Ther 63:199-207
110. Mullen CA, Coale MM, Levy AT, Stetler-Stevenson WG, Liotta LA, Brandt S, Blaese RM (1992) Fibrosarcoma cells transduced with the IL-6 gene exhibited reduced tumorigenicity, increased immunogenicity, and decreased metastatic potential. Cancer Res 52:6020-6024
111. Mullen CA, Kilstrup M, Blaese RM (1992) Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc Natl Acad Sci U S A 89:33-37
112. Mulligan LM, Matlashewski GJ, Scrable HJ, Cavanee WK (1990) Mechanisms of p53 loss in human sarcomas. Proc Natl Acad Sci U S A 87:5863-5867
113. Mulligan RC (1993) The basic science of gene therapy. Science 260:926-932
114. Murphy D, Crowther D, Renninson J, Prendiville J, Ranson M, Lind M, Patel U, Dougl M, Buckley CH, Tindall VR (1993) A randomized dose intensity study in ovarian carcinoma comparing chemotherapy given at four-week intervals for six cycles with half-dose chemotherapy given for twelve cycles. Ann Oncol 4:377-383
115. Muzyczka N (1991) Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr Topics Microbiol Immunol 158:97-129
116. Nabel GJ, Nabel EG, Yang ZY, Fox BA, Plautz GE, Gao X, Huang L, Shu S, Gordon D, Chang AE (1993) Direct gene transfer with DNA liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci U S A 90:11307-11311
117. Nabel GJ, Chang AE, Nabel EG, Plautz GE, Ensminger W, Fox BA, Felgner P, Shu S, Cho K (1994) Immunotherapy for cancer by direct gene transfer into tumors. Hum Gene Ther 5:57-77
118. Ohta Y, Tone T, Shitara T, Funato T, Jiao L, Kashian B, Scanlon KJ (1994) Hras ribozyme mediated alteration of the human melanoma phenotype. Ann NY Acad Sci 716:242-253
119. Ojeifo O, Forough R, Paik S, Maciag T, Zwiebel AJ (1995) Angiogenesis-directed implantation of genetically modified endothelial cells in mice. Cancer Res. 55:2240-2244
120. O'Shaughnessy JA, Cowan KH, Wilson W et al. (1993) Pilot study of high-dose ICE (ifosfamide, carboplatin, etoposide) chemotherapy and autologous bone marrow transplant (ABMT) with neoR transduced bone marrow and peripheral blood stem cells in patients with metastatic breast cancer. Hum Gene Ther 4:331
121. Ostrove JM (1994) Safety testing programs for gene therapy viral vectors. Cancer Gene Ther 1:125-133
122. Pardoll DM (1993) Cancer vaccines. Immunol Today 14:310-316
123. Plautz G, Nabel EG, Nabel GJ (1991) Selective elimination of recombinant genes in vivo with a suicide retroviral vector. New Biol 3:709-715
124. Plautz GE, Yang ZY, Wu BY, Gao X, Huang L, Nabel GJ (1993) Immunotherapy of malignancy by in vivo gene transfer into tumors. Proc Natl Acad Sci U S A 90:4645-4649
125. Podda S, Ward M, Himelstein A, Richardson C, Flor-Weiss E, Smith L, Gottesman MM, Pastan L, Bank A (1992) Transfer and expression of the human multiple drug resistance (MDR) gene into live mice. Proc. Natl. Acad. Sci. U S A 89:9676-9680
126. Porgador A, Bannerji R, Watanabe Y, Feldman M, Gilboa E, Eisenbach L (1993) Anti-metastatic vaccination of tumor-bearing mice with two types of IFN-gamma gene-inserted tumor cells. J Immunol 150:1458-1470
127. Porgador A, Gansbacher B, Bannerji R, Tzehoval E, Gilboa E, Feldman M, Eisenbach L (1993) Antimetastatic vaccination of tumor-bearing mice with IL-2-gene-inserted tumor cells. Int J Cancer 53:471-477
128. Quin Z, Kröger-Krasagakes S, Kunzendorf U. Hock H, Diamantstein T, Blankenstein T (1993) Expression of tumor necrosis factor by different tumor cell lines results either in tumor suppression or augmented metastasis. J Exp Med 178:355-360
129. Rabbitts TH (1994) Chromosomal translocations in human cancer. Nature 372:143-149
130. Ram Z, Culver KW, Walbridge R, Blaese RM, Oldfield EH (1993) In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res 53:83-88
131. Ram Z, Culver KW, Walbridge S, Frank JA, Blaese RM, Oldfield EH (1993) Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors. Neurosurgery 79:400-407
132. Rill DR, Moen RC, Buschle M, Bartholomew C, Foreman NK, Mirro JJ, Krance RA. Ihle JN, Brenner MK (1992) An approach for the analysis of relapse and marrow reconstitution after autologous marrow transplantation using retrovirus-mediated gene transfer. Blood 79:2694-2700
133. Rooney CM, Smith CA, Ng C, Loffin S, Li C, Krance RA, Brenner MK, Heslop HE (1995) Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 345:9-13
134. Rosenberg SA (1992) Immunization of cancer patients using autologous cancer cells modified by insertion of the gene for the tumor necrosis factor. Hum Gene Ther 3:57-73
135. Rosenberg SA (1992) Immunization of cancer patients using autologous cancer cells modified by insertion of the gene for interleukin-2. Hum Gene Ther 3:75-91
136. Rosenberg SA (1992) The immunotherapy and gene therapy of cancer. J Clin Oncol 10:180-199
137. Rosenberg SA, Aebersold P, Cornetta K, Kasid A, Morgan RA, Moen R, Karson EM, Lotze MT, Yang SC, Topalian SL (1990) Gene transfer into human: immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med 323(9):570-578
138. Rosenberg SA, Kasid A, Anderson WF (1991) TNF/TIL human gene therapy clinical protocol. Hum Gene Ther 1:443-462
139. Rosenberg SA, Anderson WF, Blaese M, et al (1993) The development of gene therapy for the treatment of cancer. Ann Surg 218:455-464
140. Rosenthal F, Zier KS, Gansbacher B (1994) Human tumor vaccines and genetic engineering of tumors with cytokine and histocompatibility genes to enhance immunogenicity. Curr Opin Oncol 6:611-615
141. Roth JA, Mukhopadhyay T, Zhang WW, Fujiwara T, Georges R (1994) Gene replacement strategies for the prevention and therapy of cancer. Eur J Cancer 30A:2032-2037
142. Rowley JD (1990) Molecular cytogenetics: Rosetta stone for understanding cancer. Clowes award lecture. Cancer Res 50:3816-3825
143. Russell SJ (1994) Replicating vectors for cancer therapy: a question of strategy. Cancer Biol 5:437-443
144. Russell SJ, Brandenburger A, Flemming CL, Collins MKL, Rommelaere J (1992) Transformation-dependent expression of interleukin genes delivered by a recombinant parvovirus. J Virol 66:2821-2828
145. Russell SJ, Hawkins RE, Winter G (1993) Retroviral vectors displaying functional antibody fragments. Nucleic Acids Res 21:1081-1085
146. Salvadori S, Gansbacher B, Pizzimenti A, Zier K (1994a) Abnormal signal transduction by T cells of mice with parental tumors is not seen in mice bearing IL-2-secretine tumors. J Immunol 153:5176-5182
147. Schmidt-Wolf G, Schmidt-Wolf IGH (1995) Cytokines and clinical gene therapy. Eur J Immunol 25:1137-1140
148. Schmidt-Wolf GD, Schmidt-Wolf IGH (1995) Cytokines and gene therapy. Immunol Today 16:173-175
149. Schmidt-Wolf IGH, Negrin RS, Kiem HP, Blume KG, Weissman IL (1991) Use of a SCID mouse/human lymphoma model to evaluate cytokine induced killer cells with potent anti-tumor cell activity. J Exp Med 174:139-149
150. Schmidt-Wolf IGH, Neubauer A, Finke S, Csipai M, Wittig B, Huhn D (1994) Interleukin-7 gene therapy for patients with metastatic colon cancer, renal cell cancer, malignant melanoma or lymphoma. Hum Gene Ther 5:1161-1168
151. Shaw YT, Chang SH, Chiou ST, Chang WC, Lai MD (1993) Partial reversion of transformed phenotype of B104 cancer cells by antisense nucleic acids. Cancer Lett 69:27-32
152. Shirasawa S, Furuse M, Yokoyama N, Sasazuki T (1993) Altered growth of human colon cancer cell lines disrupted at activated K-ras. Science 260:85-88
153. Shrivastova S, Zou A, Pirollo K, Blattner S, Chang E (1990) Germline transmission of a mutated p53 gene in a cancer-prone family with Li Fraumeni syndrome. Nature 348:747-749
154. Sikora K (1994) First 5 years of gene therapy for cancer. Lancet 344:1631
155. Simon SM, Schindler M (1994) Cell biological mechanisms of multidrug resistance in tumors. Proc Natl Acad Sci U S A 91:3497-3504
156. Solomon E, Borrow J, Goddard AD (1991) Chromosome aberrations and cancer. Science 254:1153-1160
157. Sorrentino BP, Brandt SJ, Bodine D, Gottesman MM, Pastan I, Cline A, Nienhuis AW (1992) Retroviral transfer of the human MDR1 gene permits selection of drug-resistant bone marrow cells in vivo. Science 257:99-103
158. Steele C, Cowsert LM, Shillitoe EJ (1993) Effects of human papillomavirus type-18-specific antisense oligonucleotides on the transformed phenotype of human carcinoma cell lines. Cancer Res 53:2330-2337
159. Stratford-Perricaudet LD, Perricaudet M (1994) Gene therapy: the advent of adenovirus. In: Wolff JA (ed) Gene therapeutics: methods and applications of direct gene transfer. Birkhäuser, Boston, pp 344-362
160. Sutter G, Moss B (1992) Nonreplicating vaccinia vector efficiently expresses recombinant genes. Proc Natl Acad Sci U S A 89:10847-10851
161. Tahara H, Lotze MT, Robbins PD, Storkus WJ, Zitvogel L (1995) Clinical protocol. IL-12 gene therapy using direct injection of tumors with genetically engineered autologous fibroblasts. Hum Gene Ther 6:1607-1624
162. Teng MN, Park BH, Koeppen HKW, Tracey KJ, Fendley BM, Schreiber H (1991) Long-term inhibition of tumor growth by tumor necrosis factor in the absence of cachexia or T-cell immunity. Proc Natl Acad Sci USA 88:3535-3539
163. Tepper RI, Mule JJ (1994) Experimental and clinical studies of cytokine gene-modified tumor cells. Hum Gene Ther 5:153-164
164. Toi M, Bicknell R, Harris AL (1992) Inhibition of colon and breast carcinoma cell growth by interleukin-4. Cancer Res 52:275-279
165. Tolstoshev P (1993) Gene therapy, concepts, current trials and future directions. Annu Rev Pharmacol Toxicol 32:573-596
166. Trojan J, Blossey BK, Johnson RT (1992) Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of the insulin-like growth factor-1. Proc Natl Acad Sci U S A 89:4874-4878
167. Trojan J, Johnson TR, Rudin SD (1993) Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor 1 RNA. Science 259:94-97
168. Uckert W, Walther W (1994) Retrovirus-mediated gene transfer in cancer gene therapy. Pharmacol Ther 63:323-347
169. van der Eb MM, Fallaux FJ, de Roos WK, Marinelli AW, Cramer SJ, van Ormondt H, van der Eb AJ, Bout A, Borel-Rinkes IH, van de Velde CJH, Hoeben RC (1995) Towards gene therapy for colorectal liver metastases: isolated-liver perfusion for liver-specific gene-delivery with recombinant adenovirus vectors. Gene Ther 2 [Suppl 1]:S27
170. Vanhaesebroek B, Mareel M, Van Roy F, Grooten J, Fiers W (1991) Expression of the tumor necrosis factor gene in tumor cells correlates with reduced tumorigenicity and reduced invasiveness in vivo. Cancer Res 51:2229-2238
171. Vile RG (1994) Tumor-specific gene expression. Semin Cancer Biol 5:429-436
172. Vile RG (1995) Cancer therapy. Less blood means more sanguinity. Curr Biol 5:10-13
173. Vile RG, Hart IR (1993) In vitro and in vivo targeting of gene expression to melanoma cells. Cancer Res 53:962-967
174. Vile RG, Hart IR (1993) Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA. Cancer Res 53:3860-3864
175. Vile R, Russell SJ (1994) Gene transfer technologies for the gene therapy of cancer. Gene Ther 1:88-98
176. Vile RG, Russell SJ (1995) Retroviruses as vectors. Br Med Bull 51:12-30
177. Walsh CE, Liu JM, Xiao X, Young NS, Nienhuis AW (1992) Regulated high level expression of a human gamma-globin gene introduced into erythroid cells by an adeno-associated virus vector. Proc Natl Acad Sci U S A 89:7257-7261
178. Walther W, Huth J, Sparmann G, Uckert W (1992) Retroviral transduction of the human TNF alpha gene into tumor cells generates a growth inhibitory effect. In: Malavasi F, Cortese R, Albertini A (eds) European biotechnology today - the impact of basic sciences on diagnosis and therapy. Intercept. Andover, UK, pp 209-216
179. Walther W, Fichtner I, Uckert W (1993) Retrovirus-mediated gene transfer of tumor necrosis factor alpha into colon carcinoma cells generates a growth inhibition. Anticancer Res 13:1565-1574
180. Weinberg RA (1991) Tumor suppressor genes. Science 254:1138-1146
181. Widmer MB, Morrissey PJ, Namen AE, Voice RF, Watson JD (1990) Interleukin 7 stimulates growth of fetal thymic precursors of cytolytic cells: induction of effector function by interleukin 2 and inhibition by interleukin 4. Int Immun 2:1055-1061
182. Williams RS, Johnston SA, Riedy M, et al (1991) Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles. Proc Natl Acad Sci U S A 88:2726-2730
183. Wu GY, Wilson JM, Shlahy F, Grossman M, Shafritz DA, Wu CH (1991) Receptor-mediated gene delivery in vivo. J Biol Chem 266:14338-14342
184. Yee D, Paik S, Lebovic G, et al (1989) Analysis of IGF-1 expression in malignancy - evidence for a paracrine role in human breast cancer. Mol Endocrinol 3:509-517
185. Yu JS, Wei MX, Chiocca EA, Martuza RL, Tepper RI (1993) Treatment of glioma by engineered interleukin-4 secreting cells. Cancer Res 53:3125-3128
186. Zatloukal K, Schmidt W, Cotten M, Wagner E, Stingl G, Birnstiel ML (1993) Somatic gene therapy for cancer: the utility of transferinfection in generating 'tumor vaccines'. Gene 135:199-207
187. Zenke M, Steinlein P, Wagner E, Matthew C, Beug H, Birnstiel ML (1990) Receptor-mediated endocytosis of transferrin-polycation conjugates: an efficient way to introduce DNA into hematopoietic cells. Proc Natl Acad Sci U S A 87:3655-3659
188. Zhang Y, Mukhopadhyay T, Donehower LA, Georges RN, Roth JA (1993) Retroviral vector-mediated transduction of K-ras antisense RNA into human lung cancer cells inhibits expression of the malignant phenotype. Hum Gene Ther 4:451-460
189. Zier K, Gansbacher B (1995) The impact of gene therapy on T cell function in cancer. Hum Gene Ther 6:1259-1264
190. Zwiebel JA, Su N, MacPherson A, Davis T, Ojeifo J (1993) The gene therapy of cancer: transgenic immunotherapy. Semin Hematol 30:119-129